Search Within

Joachim Yahalom

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (46)
  2. Journal Article (40)
Groups
  1. Biostatistics Service (86)
  2. Epidemiology and Biostatistics (86)
  3. Radiation Oncology, Department of (86)
  4. Survivorship Research (86)
  5. Department of Medicine (66)
  6. Hematologic Malignancies, Division of (64)

More Groups

People
  1. Zhigang Zhang (32)
  2. Andrew Zelenetz (29)
  3. Craig Moskowitz (29)
  4. Brandon Imber (25)
  5. Maria Palomba (22)
  6. Alison Moskowitz (20)

More People

Years
  1. 2024 (6)
  2. 2023 (11)
  3. 2022 (4)
  4. 2021 (6)
  5. 2020 (6)
  6. 2019 (3)

More Years

Publications
  1. Blood (20)
  2. International Journal of Radiation Oncology, Biology, Physics (16)
  3. Hematological Oncology (9)
  4. Journal of Clinical Oncology (8)
  5. Blood Advances (5)
  6. Biology of Blood and Marrow Transplantation (3)

More Publications

Publishers
  1. American Society of Hematology (25)
  2. Elsevier Inc. (21)
  3. Wiley Blackwell (10)
  4. American Society of Clinical Oncology (8)
  5. Nature Publishing Group (4)
  6. Oxford University Press (4)

More Publishers

Results (86)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Central nervous system bridging radiotherapy (CNS-BRT) achieves rapid cytoreduction prior to car T-cell therapy for aggressive B-cell lymphomas
    Meeting Abstract

    Cederquist, G.; Schefflein, J.; Devlin, S.; Shah, G.; Shouval, R.; Hubbeling, H.; Tringale, K.; Fregonese, B.; Hajj, C.; Boardman, A.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Associations between genetic alterations in follicular lymphoma and radiosensitivity
    Meeting Abstract

    Wijetunga, N. A.; Lebow, E. S.; Chan, A.; Lee, J.; Fregonese, B.; Seshan, V.; Hajj, C.; Cederquist, G.; Hubbeling, H. G.; Ma, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Improvement in radiomic features following bridging therapy is prognostic for CD19 chimeric antigen receptor (CAR) T-cell therapy outcome
    Meeting Abstract

    Hubbeling, H. G.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G. L.; Fregonese, B.; Bedmutha, A.; Boardman, A.; Dahi, P. B.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Outcomes and relapse patterns in primary central nervous system lymphoma: Longitudinal analysis of 559 patients diagnosed from 1983 to 2020
    Journal Article

    Tringale, K. R.; Scordo, M.; Yahalom, J.; White, C.; Zhang, Z.; Vachha, B.; Cederquist, G.; Schaff, L.; Deangelis, L.; Grommes, C.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Metabolic tumor volume response after bridging therapy determines chimeric antigen receptor T-cell outcomes in large B-cell lymphoma
    Journal Article

    Hubbeling, H.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G.; Fregonese, B.; Wills, B.; Bedmutha, A.; Alarcon Tomas, A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomas
    Journal Article

    Cederquist, G. Y.; Schefflein, J.; Devlin, S. M.; Shah, G. L.; Shouval, R.; Hubbeling, H.; Tringale, K.; Tomas, A. A.; Fregonese, B.; Hajj, C.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Genetic alterations of follicular lymphoma can predict response to very low dose radiotherapy
    Meeting Abstract

    Wijetunga, N. A.; Lebow, E.; Chan, A.; Fregonese, B.; Seshan, V.; Hajj, C.; Cederquist, G.; Hubbeling, H.; Ma, J.; Sarkar, R. R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • CNS radiotherapy as bridging prior to CAR T-cell therapy for non-Hodgkin B-cell lymphoma
    Meeting Abstract

    Cederquist, G.; Schefflein, J.; Devlin, S. M.; Hubbeling, H.; Tringale, K.; Shah, G. L.; Tomas, A. A.; Shouval, R.; Hajj, C.; Fregonese, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Treatment outcomes of limited stage grade 3A follicular lymphoma
    Meeting Abstract

    Sarkar, R. R.; Lee, J.; Zhang, Z.; Zelenetz, A. D.; Salles, G.; Yahalom, J.; Imber, B. S.
    Blood (2023)

    Fulltext@MSK | Save
  • Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T-cell therapy outcome
    Meeting Abstract

    Hubbeling, H.; Leithner, D.; Silverman, E. A.; Flynn, J. R.; Devlin, S. M.; Shah, G. L.; Fregonese, B.; Bedmutha, A.; Wills, B.; Tomas, A. A.; more...
    Blood (2023)

    Fulltext@MSK | Save